Company Filing History:
1 out of 60 
1 out of 1 Years Active: 2020
Title: Yohei Kurosaki: Innovator in Viral Detection Technology
Introduction
Yohei Kurosaki is a notable inventor based in Nagasaki, Japan. He has made significant contributions to the field of viral detection, particularly in relation to the Zaire ebola virus. His innovative work has implications for public health and disease management.
Latest Patents
Kurosaki holds a patent for a primer set designed for the detection of the Zaire ebola virus, assay kit, and amplification method. This patent includes a nucleic acid primer set that amplifies a ZEBOV gene. The F1 sequence consists of at least 13 consecutive bases included in SEQ ID NO: 31 or 64. The F2 sequence includes at least 13 bases from SEQ ID NO: 62 or 63. The F3 sequence comprises at least 13 bases from SEQ ID NO: 29, 36, 38, 55, 56, 57, 58, 59, 60, 61, or 61. Additionally, the B1c sequence contains at least 13 bases from SEQ ID NO: 68, 69, 70, 71, 72, 73, 74, or 75. The B2c sequence includes at least 13 bases from SEQ ID NO: 65 or 66, while the B3c sequence consists of at least 13 bases from SEQ ID NO: 34, 67, 82, or 83. This patent highlights his expertise in molecular biology and diagnostics.
Career Highlights
Throughout his career, Kurosaki has worked with prestigious institutions, including Nagasaki University and Canon Medical Systems Corporation. His experience in these organizations has allowed him to develop and refine his innovative ideas in the field of medical technology.
Collaborations
Kurosaki has collaborated with Jiro Yasuda, further enhancing his research and development efforts in viral detection technologies.
Conclusion
Yohei Kurosaki's contributions to the field of viral detection, particularly through his patent for the Zaire ebola virus detection method, showcase his innovative spirit and dedication to improving public health. His work continues to have a lasting impact on the medical community.